1. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases. Issue 6 (8th November 2018) Authors: Wannick, Melanie; Bezdek, Siegfried; Guillen, Nathalie; Thieme, Markus; Meshrkey, Fibi; Mousavi, Sadegh; Seeling, Michaela; Nimmerjahn, Falk; Mócsai, Attila; Zillikens, Detlef; Sezin, Tanya; Sadik, Christian D. Journal: Pharmacology research & perspectives Issue: Volume 6:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗